Trials / Unknown
UnknownNCT03072979
A Study to Quantify Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)
Reduction in Tumour Perfusion for Spine Metastasis Treated With Stereotactic Body Radiotherapy (SBRT)
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 18 (estimated)
- Sponsor
- National University Hospital, Singapore · Academic / Other
- Sex
- All
- Age
- 21 Years
- Healthy volunteers
- Not accepted
Summary
Pre-clinical evidence suggests that radiotherapy reduces tumour-associated vasculature. The investigators will conduct a single-arm prospective study to quantify the reduction in tumour vasculature post-radiotherapy
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| RADIATION | Stereotactic body radiotherapy | Stereotactic body radiotherapy |
Timeline
- Start date
- 2017-01-21
- Primary completion
- 2017-12-31
- Completion
- 2018-12-31
- First posted
- 2017-03-08
- Last updated
- 2017-03-08
Locations
1 site across 1 country: Singapore
Source: ClinicalTrials.gov record NCT03072979. Inclusion in this directory is not an endorsement.